FLCN expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.851700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.467000E-01
Normal-vs-Stage2
3.773800E-02
Normal-vs-Stage3
8.439700E-04
Normal-vs-Stage4
2.372400E-01
Stage1-vs-Stage2
5.706800E-01
Stage1-vs-Stage3
1.932610E-01
Stage1-vs-Stage4
7.630800E-01
Stage2-vs-Stage3
1.438040E-01
Stage2-vs-Stage4
7.967600E-01
Stage3-vs-Stage4
2.582000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.647800E-02
Normal-vs-AfricanAmerican
8.225800E-02
Normal-vs-Asian
3.194400E-02
Caucasian-vs-AfricanAmerican
9.494800E-01
Caucasian-vs-Asian
5.394600E-01
AfricanAmerican-vs-Asian
6.372400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.337700E-02
Normal-vs-Female
7.864200E-02
Male-vs-Female
7.462400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.391600E-01
Normal-vs-Age(41-60Yrs)
1.398400E-01
Normal-vs-Age(61-80Yrs)
1.517510E-02
Normal-vs-Age(81-100Yrs)
6.382300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.411200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.781600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.966770E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.317800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.629240E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.598400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.188260E-02
Normal-vs-Daily Drinker
4.356700E-03
Normal-vs-Weekly Drinker
5.788400E-01
Normal-vs-Occasional Drinker
2.418500E-02
Normal-vs-Social Drinker
6.655700E-02
Non Drinker-vs-Daily Drinker
3.985200E-01
Non Drinker-vs-Weekly Drinker
7.900200E-02
Non Drinker-vs-Occasional Drinker
4.762800E-01
Non Drinker-vs-Social Drinker
6.903800E-02
Daily Drinker-vs-Weekly Drinker
3.430100E-02
Daily Drinker-vs-Occasional Drinker
1.481190E-01
Daily Drinker-vs-Social Drinker
1.377700E-02
Weekly Drinker-vs-Occasional Drinker
1.697970E-01
Weekly Drinker-vs-Social Drinker
4.580600E-01
Occasional Drinker-vs-Social Drinker
2.676400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.607600E-01
Normal-vs-Grade 2
7.530400E-01
Normal-vs-Grade 3
7.510600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.331000E-01
Grade 1-vs-Grade 3
7.882000E-01
Grade 1-vs-Grade 4
7.607600E-01
Grade 2-vs-Grade 3
9.281600E-01
Grade 2-vs-Grade 4
7.530400E-01
Grade 3-vs-Grade 4
7.510600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.784500E-03
Normal-vs-NonDiabetic
6.856300E-02
Diabetic-vs-NonDiabetic
1.293400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.543810E-02
Normal-vs-NoPancreatitis
5.441900E-02
Pancreatitis-vs-NoPancreatitis
6.124200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.451870E-02
Normal-vs-N1
5.469500E-02
N0-vs-N1
4.584600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.007670E-02
Normal-vs-TP53-NonMutant
1.085200E-01
TP53-Mutant-vs-TP53-NonMutant
3.018000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
